跳至主要内容
临床试验/ISRCTN21530271
ISRCTN21530271已完成不适用

Effects of combining a plant stanol enriched yogurt drink and a low dose statin on markers for inflammation and endothelial function and serum lipoprotein concentrations

utrition and Toxicology Research Institute Maastricht (NUTRIM) (Netherlands)0 个研究点目标入组 132 人开始时间: 2005年12月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
132

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Stable dietary habits
  • 2. Men 55?70 years of age
  • 3. Men 45?54 and women 55-70 years of age with at least one of the following criteria:
  • 3.1. Familial history of coronary heart disease (CHD) in first degree relatives (parent/brother/sister). Only CHD in male relatives below 55 years and in female relatives below 65 years is considered.
  • 3.2. Overweight as defined by body mass index (BMI) >25 (as calculated from weight and length) or abdominal obesity (waist circumference >102 cm for men, >88 cm for women)

排除标准

  • 1. Smoking
  • 2. Active cardiovascular disease like congestive heart failure or recent (< 6 months) event (acute myocardial infarction, CVA)
  • 3. Peripheral vascular disease
  • 4. Familial hypercholesterolemia
  • 5. Impairment of renal function, as evidenced by increased serum creatinine >150 mmol/l
  • 6. Hepatic diseases as manifested by alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyltransferase (GGT), total bilirubin or alkaline phosphatase (ALP) >2 times the upper limit of normal
  • 7. Severe medical conditions that might interfere with the study such as epilepsy, asthma, chronic obstructive pulmonary disease (COPD), inflammatory bowel diseases, and rheumatoid arthritis
  • 8. Use of medication such as corticosteroids, diuretics or lipid lowering medication including statin use in the prior 2 months
  • 9. Hypersensitivity to simvastatin or any excipient
  • 10. Previous history of muscular toxicity with a statin or fibrate
  • 11. Concomitant use of potent CYP3A4 inhibitors (e.g. itraconazole, ketoconazole, human immunodeficiency virus [HIV] protease inhibitors, erythromycin, clarithromycin, telithromycin, nefazodone)
  • 12. Unstable body weight (weight gain or loss >3 kg in the past three months)
  • 13. Abnormal hematological profile
  • 14. Abuse of drugs and/or alcohol
  • 15. Pregnant or breastfeeding women
  • 16. Use of sterol or stanol ester products within the previous 30 days
  • 17. Participation in another study within 1 month prior to the screening visit
  • 18. Having donated blood (as blood donor) within 1 month prior to the screening visit or planning to do so during the study

研究者

发起方
utrition and Toxicology Research Institute Maastricht (NUTRIM) (Netherlands)

相似试验